Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Therapeutic efficacy and safety of long-term stored hemoglobin-vesicles in a rat model of hemorrhagic shock

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-C-035-Tuesday
  • By: TOKUNO, Masahiro (Sojo University, Kumamoto, Japan)
  • Co-author(s): Masahiro Tokuno: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan
    Kazuaki Taguchi: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan
    Keishi Yamasaki: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;DDS Research Institute, Sojo University, Kumamoto, Japan
    Hiromi Sakai: Department of Chemistry, Nara Medical University, Nara, Japan
    Masaki Otagiri: Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan;DDS Research Institute, Sojo University, Kumamoto, Japan
  • Abstract:

    Backgrounds

    Hemoglobin-vesicles (HbV) have been developed as red blood cell (RBC) substitutes. In vitro experiments showed that HbV suspensions are structurally and physicochemically stabile for a year, which indicate that HbV can be stored for more than 1 year. However, it remains unclear that long-term stored HbV administration could effectively..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses